A recent review looked at ultrasound-driven mechanical immunomodulation as a potential approach for treating tumors. The authors examined the current state of this technology and its potential effects on cancer cells. However, the review did not report specific results, sample sizes, or safety data because this is an early assessment of the field.
The study highlights several important challenges that must be solved before this method can be used in patients. These challenges include standardizing dosimetry, ensuring cavitation reproducibility, and improving targeting accuracy. Researchers also noted the difficulty of balancing potential efficacy with safety concerns.
Another significant issue is cell-type-specific heterogeneity, meaning the treatment might work differently on various cells. Because this is a review of early concepts rather than a completed clinical trial, readers should be cautious. This information is not yet ready to change medical practice or offer hope for immediate treatment options.